Increasing diabetic population to drive the growth of the India vildagliptin market.
According to TechSci Research report, “India Vildagliptin Market By Composition, By Source, By Strength, By Distribution Channel, By Application, By Company, By Region, Forecast & Opportunities, FY2026”, the India vildagliptin market is expected to grow at a steady rate during the forecast period on account of high usage of vildagliptin to reduce hyperglycemia in patients suffering from type 2 diabetes mellitus. Continuous growth in research and developmental activities is projected to fuel the market growth through FY2026. Government initiatives and supportive policies for the pharmaceutical industry are further expected to positively contribute to the market growth in the forthcoming years. Furthermore, growing awareness about anti-hyperglycemic drugs is making headway for the growth of the India vildagliptin market in years to come. However, there are certain factors that might act as major impediments to the growth of India vildagliptin market during the forecast period such as side effects of drug consumption like nausea, hypoglycemia, tremor, headache and dizziness. The patents for vildagliptin in India, which were held by Novartis, got expired in December 2019, leading to the opening up of the opportunities in the generic drug market and increasing competition amongst competitors. This is projected to bolster the market growth for India vildagliptin market in the forthcoming years.
Browse XX market data tables and XX figures spread through XXX pages and an in-depth TOC on “ India Vildagliptin Market”
https://www.techsciresearch.com/report/india-vildagliptin-market/7276.html
The India vildagliptin market is segmented based on composition, source, strength, distribution channel, application, company, and region. Based on the distribution channel, the market can be fragmented into online vs. offline. The offline channel is expected to dominate the market which is attributable to the fact that consumers prefer buying medicines from a pharmacy or drug store located nearby. The online segment is also expected to register significant growth over the next few years. This can be ascribed to the emergence of several online pharmacies and doorstep drug delivery by e-commerce platforms across the country. In terms of application, the market is categorized into type 2 diabetes mellitus vs. hyperglycemia, out of which, type 2 diabetes mellitus held the largest market share until FY2020 and is further estimated to maintain its dominance in the next 5 years as well. This is accredited to a high percentage of the population having type 2 diabetes mellitus in India.
Abbott India Limited, Torrent Pharmaceuticals Limited, Intas Pharmaceuticals Limited, Dr. Reddy’s Laboratories Ltd., IPCA Laboratories Ltd., Lupin Limited, Piramal Enterprises Ltd. (Piramal Pharma), Novartis India Limited, Cipla Ltd., Alembic Pharmaceuticals Ltd, and others are some of the leading players operating in India vildagliptin market. The key market players operating in the market are using organic go-to-market strategies such as product launches, mergers and acquisitions, research collaborations, and joint ventures to boost their market share and to expand their geographic reach.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7276
Customers can also request for 10% free customization on this report.
“India vildagliptin market is expected to witness steady growth in the coming years on account of rising disorders of the musculo-skeletal system amongst the population. During all stages of pain treatment, this drug is usually used in combination with sedatives, antidepressants, and anti-epileptics as vildagliptin is the most commonly used painkiller. Also, continuous innovation in the field of vildagliptin drugs for treating diabetes in India is another key factor which is expected to create lucrative opportunities for the market growth over the next five years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based India management consulting firm.
“India Vildagliptin Market By Composition, By Source, By Strength (50 mg, 100mg, Others), By Distribution Channel, By Application, By Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India vildagliptin market and provides statistics and information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the India vildagliptin market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
